Literature DB >> 12151648

Dichloroacetate stimulates glycogen accumulation in primary hepatocytes through an insulin-independent mechanism.

Melissa K Lingohr1, Richard J Bull, Junko Kato-Weinstein, Brian D Thrall.   

Abstract

Dichloroacetate (DCA), a by-product of water chlorination, causes liver cancer in B6C3F1 mice. A hallmark response observed in mice exposed to carcinogenic doses of DCA is an accumulation of hepatic glycogen content. To distinguish whether the in vivo glycogenic effect of DCA was dependent on insulin and insulin signaling proteins, experiments were conducted in isolated hepatocytes where insulin concentrations could be controlled. In hepatocytes isolated from male B6C3F1 mice, DCA increased glycogen levels in a dose-related manner, independently of insulin. The accumulation of hepatocellular glycogen induced by DCA was not the result of decreased glycogenolysis, since DCA had no effect on the rate of glucagon-stimulated glycogen breakdown. Glycogen accumulation caused by DCA treatment was not hindered by inhibitors of extracellular-regulated protein kinase kinase (Erk1/2 kinase or MEK) or p70 kDa S6 protein kinase (p70(S6K)), but was completely blocked by the phosphatidylinositol 3-kinase (PI3K) inhibitors, LY294002 and wortmannin. Similarly, insulin-stimulated glycogen deposition was not influenced by the Erk1/2 kinase inhibitor, PD098509, or the p70(S6K) inhibitor, rapamycin. Unlike DCA-stimulated glycogen deposition, PI3K-inhibition only partially blocked the glycogenic effect of insulin. DCA did not cause phosphorylation of the downstream PI3K target protein, protein kinase B (PKB/Akt). The phosphorylation of PKB/Akt did not correlate to insulin-stimulated glycogenesis either. Similar to insulin, DCA in the medium decreased IR expression in isolated hepatocytes. The results indicate DCA increases hepatocellular glycogen accumulation through a PI3K-dependent mechanism that does not involve PKB/Akt and is, at least in part, different from the classical insulin-stimulated glycogenesis pathway. Somewhat surprisingly, insulin-stimulated glycogenesis also appears not to involve PKB/Akt in isolated murine hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151648     DOI: 10.1093/toxsci/68.2.508

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  6 in total

1.  BNip3 regulates mitochondrial function and lipid metabolism in the liver.

Authors:  Danielle Glick; Wenshuo Zhang; Michelle Beaton; Glenn Marsboom; Michaela Gruber; M Celeste Simon; John Hart; Gerald W Dorn; Matthew J Brady; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

2.  Metabolic Disruption Early in Life is Associated With Latent Carcinogenic Activity of Dichloroacetic Acid in Mice.

Authors:  Leah C Wehmas; Anthony B DeAngelo; Susan D Hester; Brian N Chorley; Gleta Carswell; Greg R Olson; Michael H George; Julia H Carter; Sandra R Eldridge; Anna Fisher; Beena Vallanat; Charles E Wood
Journal:  Toxicol Sci       Date:  2017-10-01       Impact factor: 4.849

3.  PCB 126 and other dioxin-like PCBs specifically suppress hepatic PEPCK expression via the aryl hydrocarbon receptor.

Authors:  Wenshuo Zhang; Robert M Sargis; Paul A Volden; Christopher M Carmean; Xiao J Sun; Matthew J Brady
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

Review 4.  Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

Authors:  Jane C Caldwell; Nagalakshmi Keshava
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

5.  Dichloroacetate induces protective autophagy in LoVo cells: involvement of cathepsin D/thioredoxin-like protein 1 and Akt-mTOR-mediated signaling.

Authors:  F Gong; X Peng; Y Sang; M Qiu; C Luo; Z He; X Zhao; A Tong
Journal:  Cell Death Dis       Date:  2013-11-07       Impact factor: 8.469

Review 6.  Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy.

Authors:  Christos E Zois; Adrian L Harris
Journal:  J Mol Med (Berl)       Date:  2016-02-17       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.